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Reports regarding gender-related differences in COPD expression have provided conflicting results. In the French
Initiatives BPCO real-world cohort, which contained 688 patients (146 women) when data were extracted, women
were matched with men (1:3 ratio: n = 107:275) on age (5-year intervals) and FEV1 (5% predicted intervals) and
comparisons were performed using univariate logistic regressions. For a given age and level of airflow obstruction,
women with COPD had higher BOD scores due to more pronounced dyspnea and lower BMI, suggesting worse
prognosis, and were more likely to exhibit anxiety, suggesting the need for specific assessment and care.
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Several analyses of data from observational or interven-
tional studies have been performed to assess gender-
related differences in the risk and/or expression of
COPD. However, results have been somehow contra-
dictory, some [1-3] but not all [4,5] studies finding more
severe expression of COPD in women. Discrepancies
might in part relate to differences between studies in
terms of genetic background and exposure to risk factors
other than cigarette smoking, including occupational or
domestic exposures [6,7]. Another explanation could be
confounding by severity of airflow limitation [4,8]. To
explore whether the clinical expression of the disease is
affected by gender in a real-life COPD population, we
performed a matched analysis of men and women of the
INITIATIVES BPCO cohort. The main goal was to
determine whether, for a given age and level of airflow
obstruction, clinical features were different in women.Methods
COPD subjects included in the present analysis were
recruited in the INITIATIVES BPCO cohort between* Correspondence: nicolas.roche@cch.aphp.fr
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unless otherwise stated.January 2005 and June 2010. INITIATIVES BPCO is
an ongoing real-world rolling cohort of spirometry-
diagnosed COPD patients (post-bronchodilator FEV1/
FVC ratio < 70%) identified in 17 pulmonary units of
university hospitals located throughout France, which
has already been described in details [9,10]. Data are
recorded in a standardized case report form but, due
to the real-world nature of patient’s care, only demo-
graphic characteristics and spirometry are mandatory
to include a patient. The study was approved by the Ethics
Committee of Versailles (France), and all subjects pro-
vided informed written consent.
Women and men were matched (1:3) on age (5-year
intervals) and FEV1 (5% predicted intervals). Relations
between gender and other variables were first analyzed
using univariate logistic regressions. To obtain estimates
of patients’ prognosis, BOD scores were calculated using
Body-Mass Index, FEV1 level and MRC dyspnea grade,
as previously described [10].Results
When the database was extracted, the INITIATIVES
BPCO cohort contained data on 688 COPD subjects in-
cluding 146 women (21%). Altogether, 107 women (73%
of the whole female population) could be matched with
275 men (51% of the whole male population). Table 1Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Characteristics of the studied population and
univariate comparisons (univariate logistic regression
analyses) between age- and FEV1-matched (3:1 ratio)
men (n = 275) and women (n = 107)
Variable Men Women P value
Age* 63 [57–71] 63 [56–70] 0.68
Pack-years 41 [25–55] 40 [30–55] 0.65
BMI 25 (22–29) 24 (20–28) 0.02
FEV1 (%)* 46 [36–62] 47 [37–65] 0.71
Exacerbations/patient/year 1 [0–2] 1 [0–2] 0.56
Dyspnea (MRC) 1 [1,2] 2 [1-3] 0.0003
SGRQ total 43 [30–59] 46 [32–60] 0.35
BOD index 2 [1-4] 3 [1-4] <0.0001
Denutrition BMI ≤18.5 kg/m2 8% 18% 0.004
Obesity BMI > 30 kg/m2 21% 15% 0.18
Comorbid asthma 13% 10% 0.42
Seasonal rhinitis 9% 16% 0.04
Occupational exposure 41% 15% <0.0001
Chronic bronchitis 68% 70% 0.84
Hypertension 35% 33% 0.71
Left heart failure 10% 15% 0.12
Ischemic heart disease 15% 7% 0.10
Peripheral artery disease 13% 10% 0.58
Diabetes mellitus 14% 9% 0.25
Sleep apnea syndrome 8% 2% 0.04
Anxiety (HAD anxiety ≥10) 29% 41% 0.02
Depression (HAD Depression ≥10) 15% 23% 0.56
*Indicate matching variables. Data are median [Q1–Q3] or %.
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Univariate logistic regression analyses found that female
gender was associated with a lower frequency of exposure
to occupational risk factors, more frequent impairment of
nutritional status, higher dyspnea grades and BOD scores
and more frequent anxiety (HAD-anxiety > 10) (Table 1).
Among comorbidities, sleep apnea syndrome was more
frequent in men. Female gender tended to be associated
with a more frequent history of left heart failure.
Discussion
In the present cohort, some components of the clinical
expression of COPD, namely BMI and dyspnea, differed
between women and men for a given age and FEV1 level,
leading to higher BOD score in women. Anxiety was
also more frequent in women, while HRQOL and exac-
erbations frequency were not significantly different be-
tween men and women. One strength of this study is
that matching could be performed using rather small
age and FEV1 intervals, allowing ensuring that the twopopulations were similar regarding these variables, as
confirmed by univariate comparisons. One limitation is
that patients were recruited in pulmonary units of univer-
sity hospitals and therefore do not represent the COPD
population at large. However, it included patients with
broad levels of airflow obstruction and multiple pheno-
types [9,10], which is infrequent in most randomized trials.
One of these, the TORCH trial, which recruited patients
with moderate-to-very severe levels of airflow obstruction
[4], found that dyspnea and health status impairment were
both more pronounced in women despite higher FEV1.
In the study by de Torres et al., dyspnea was also more
intense (while cough was more frequent) in women
matched with men on FEV1% predicted [11]. Interestingly,
these authors found that factors independently associated
with dyspnea and HRQL differ between men and women,
and suggested that non-respiratory factors may contribute
more to dyspnea and HRQL in women [11]. Accordingly,
several studies found a higher rate of psychological
distress in women [12-14].
Multiple factors could explain gender-related differ-
ences in dyspnea ratings, as reviewed a few years ago by
Camp and coworkers [15]. Firstly, from a physiological
perspective, normal anatomical differences lead to re-
duced maximal ventilatory capacity, greater expiratory
flow limitation, mild decrease in end-expiratory lung
volume during exercise and increased work of breathing
in women. Secondly, among COPD patients with a given
level of airways obstruction, women exhibit more marked
airway hyperresponsiveness. Whether this observation re-
lates only to intrinsic differences in airway caliber or also
to variations in biological mechanisms is unknown. The
affective dimension of dyspnea might also differ between
men and women. Finally, hormonal influences could be
involved.
Conclusion
The present study shows that, for a given age and level
of airflow obstruction, women with COPD experience
different intensity of dyspnea than men. In addition,
women have lower BMI, which also contributes to their
higher BOD scores. Finally, anxiety appears more frequent
in women. Mechanisms underlying these differences
remain to be fully understood, but this suggests that
COPD assessment and treatment might benefit from a
more gender-specific approach.
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